SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-018465
Filing Date
2023-01-30
Accepted
2023-01-30 09:18:54
Documents
15
Period of Report
2023-01-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d434551d8k.htm   iXBRL 8-K 24703
2 EX-99.1 d434551dex991.htm EX-99.1 14302
6 GRAPHIC g434551g0128010824608.jpg GRAPHIC 3678
7 GRAPHIC g434551g0128010824715.jpg GRAPHIC 2676
  Complete submission text file 0001193125-23-018465.txt   178994

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20230126.xsd EX-101.SCH 2838
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20230126_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20230126_pre.xml EX-101.PRE 11699
9 EXTRACTED XBRL INSTANCE DOCUMENT d434551d8k_htm.xml XML 3467
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 23565478
SIC: 2836 Biological Products, (No Diagnostic Substances)